Navigation Links
Mayo Clinic breast cancer study finds new type of mutation
Date:4/15/2012

JACKSONVILLE, Fla. Mayo Clinic researchers have discovered a new class of molecular mutation in various forms of breast cancer, a finding that may shed new light on development and growth of different types of breast tumors. Called fusion transcripts, the mutated forms of RNA may also provide a way to identify tumor subtypes and offer new strategies to treat them, investigators say.

Their study, published in the April 15 issue of Cancer Research, is the first to systematically search for fusion genes and fusion transcripts linked to different types of breast tumors.

Oncologists currently recognize three basic types of breast tumors estrogen-receptor (ER)-positive, HER2-positive, and triple negative.

"But breast cancer is much more complex than indicated by these three subtypes, and one of the challenges of treating the disease is to identify gene markers that predict how a tumor will respond to a specific treatment," says senior investigator Edith Perez, M.D., deputy director of the Mayo Clinic Comprehensive Cancer Center in Florida and director of the Breast Cancer Translational Genomics Program, which involves researchers at all three Mayo Clinic campuses.

"The discovery of subtype-specific fusion transcripts in breast cancer represents a step in this direction," she says. "Our findings indicate that fusion transcripts are much more common in breast cancer than had been realized. They represent a new class of mutation whose role in breast cancer is not understood at all."

"Fusion transcripts have the power to produce proteins that are relevant to tumor development, growth, and sensitivity to treatment, so we may have a brand new set of genomic changes that may help us understand, and treat, breast cancer in a new way," says E. Aubrey Thompson, Ph.D., professor of Biology at Mayo Clinic's Comprehensive Cancer Center, and co-director of the Breast Cancer Translational Genomics Program.

"This is a novel discovery that will now require additional investigation," he says. "We need to understand what these fusion transcripts and proteins are doing."

Fusion transcripts are created when chromosomes break apart and recombine, an event that commonly occurs in cancer cells. During this process, fusion genes are created when two halves of normal genes become linked. Fusion genes (DNA) create fusion transcripts (RNA), which then produce fusion proteins.

"Mistakes are made," Dr. Thompson says. "That is one of the salient properties of tumor cells, because they are defective in repairing damage to their genes."

"These mutated proteins may have an entirely new, cancer-promoting function, or they may interfere with normal cellular functions."

Fusion transcripts are common in blood cancers, such as leukemia and lymphoma. Before this discovery, however, few were found in solid cancers such as breast tumors.

Because fusion genes, transcript, and protein are generally found only in tumors, they make ideal biomarkers to identify tumor cells, Dr. Perez says.

Also, proteins produced by fusion transcripts may be relevant to tumor growth, as has been seen in blood cancers and in lung cancer, she says.

"These transcripts may mark regions of localized chromosomal instability that are linked to growth of breast cancer. If we can develop drugs against these transcripts, they will be ideal therapeutic targets," Dr. Perez says. "We have a lot of exciting work to do in the next few years."


'/>"/>

Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. NYU Langone experts present research, clinical advances at neurosurgeons meeting
2. Mayo Clinic offers newly approved treatment for acid reflux disease
3. Mayo Clinic launches whole genome breast cancer study
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Clinical insight improves treatment with new lung cancer drug
6. First targeted nanomedicine to enter human clinical studies
7. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
8. Early clinical data show galeterone safe, effective against prostate cancer
9. Cleveland Clinic study shows bariatric surgery improves, reverses diabetes
10. Stephanie R. Wilson, MD, to be presented with the Joseph H. Holmes Clinical Pioneer Award
11. Mayo Clinic researchers building melanoma vaccine to combat skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2020)... ... , ... Canadian digital healthcare portal Ask The Doctor has launched ... the Coronavirus. , "It is our duty and it is our responsibility to help ... Prakash Chand, CEO of Ask The Doctor. , Doctors and nurses around the globe ...
(Date:2/14/2020)... ... 14, 2020 , ... ScripHessco has announced the release of ... breaks down the benefits of chiropractic care during pregnancy and how to find ... quite beneficial to the mother’s health. Seeing a chiropractor during pregnancy leads to ...
(Date:2/13/2020)... WASHINGTON (PRWEB) , ... February 13, 2020 , ... ... healthcare, non-profit and business sectors, committed to achieving health equity for all Americans ... and recommendations at a February 26th event at the National Press Club. , ...
(Date:2/13/2020)... HILLS, Calif. (PRWEB) , ... February 13, 2020 , ... ... and cosmetic procedures that people will be discussing in 2020. It also reports on ... cosmetic and surgical procedures. Dr. Jazayeri says that his patients are increasingly knowledgeable and ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... America, is pleased to announce a $5,000 grant to provide free dental care ... has generously donated to the Smiles for Everyone Foundation , which provides ...
Breaking Medicine News(10 mins):
(Date:2/13/2020)... ... 2020 , ... The global market for clinical laboratory services is estimated at ... billion in 2010, according to a new report from Kalorama Information. Kalorama classifies clinical ... is driven by an aging population and a growing incidence of chronic diseases,” said ...
(Date:2/11/2020)... ... February 11, 2020 , ... SureFire ... safety measures, is offering courses for hospital and other medical staff throughout Los ... medical practitioners like nurses, doctors, and other staff members, SureFire CPR designed a ...
(Date:2/10/2020)... ... February 11, 2020 , ... FDA Data Integrity, ... Cerulean Associates LLC and FDAnews, March 17-18, 2020, Doubletree Hotel Philadelphia Center City ... Data Integrity: For Device and Pharma Firms, and Their Suppliers Workshop ends on ...
Breaking Medicine Technology: